COMVAX - Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine
Navigation: NDC > Supplier starting with: M > MERCK SHARP & DOHME CORP.| Field | Value |
|---|---|
| NDC Code: | 0006-4898 |
| Proprietary Name: | COMVAX |
| Suffix: | |
| Non-Proprietary Name: | Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine |
| Dosage Form: | INJECTION, SUSPENSION |
| Method: | INTRAMUSCULAR |
| Original Marketing Date: | 02-10-1996 |
| Category Name: | BLA |
| Application Number: | BLA103623 |
| Labeler: | MERCK SHARP & DOHME CORP. |
| Substance Name: | HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN; HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN |
| Active Numerator Strength: | 7.5; 5 |
| Active Ingredient Unit: | ug/.5mL; ug/.5mL |
| Pharm Classes: | Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Hepatitis B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis B Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
| DEA Schedule: |